<SEC-DOCUMENT>0001838139-25-000010-index.html : 20251217
<SEC-HEADER>0001838139-25-000010.hdr.sgml : 20251217
<ACCEPTANCE-DATETIME>20251217174316
ACCESSION NUMBER:		0001838139-25-000010
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251216
FILED AS OF DATE:		20251217
DATE AS OF CHANGE:		20251217

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Urist Marshall
		CENTRAL INDEX KEY:			0001838139
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39329
		FILM NUMBER:		251580437

	MAIL ADDRESS:	
		STREET 1:		C/O ROYALTY PHARMA PLC
		STREET 2:		110 EAST 59TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Royalty Pharma plc
		CENTRAL INDEX KEY:			0001802768
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		110 EAST 59TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 883-0200

	MAIL ADDRESS:	
		STREET 1:		110 EAST 59TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1766011394.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1766011394.html

Document 1 - RAW XML: wk-form4_1766011394.xml

</DOCUMENT>
</SEC-DOCUMENT>